Literature DB >> 3877459

Granulopoiesis in patients with congenital neutropenia.

Y Kawaguchi, M Kobayashi, A Tanabe, M Hara, Y Nishi, T Usui, S Nagai, Y Nishibayashi, K Nagao, K Yokoro.   

Abstract

Granulopoiesis was investigated in five patients with congenital neutropenia (CN) (one Kostmann type, four benign forms). In semisolid agar culture, the marrow cells of all five patients produced normal numbers of CFU-c (colony-forming unit-culture). The size and classification of colonies were normal. In suspension culture in vitro with exogenous colony-stimulating factor (CSF) generated from omental-conditioned medium (OMCM), the myeloid precursors of all patients could proliferate and differentiate into normal polymorphonuclear neutrophils (PMNs). But in the absence of exogenous CSF, myeloid precursors of the patient with Kostmann-type CN did not proliferate or differentiate into PMNs at all. In the four patients with benign neutropenia, however, PMNs were found even without exogenous CSF similar to normal individuals. These results suggest that patients with CN may have normal granulopoietic stem cells with normal proliferative and differentiating capacity in response to exogenous CSF. When a small amount of normal human serum was added to normal marrow cultures stimulated by exogenous CSF, the colony growth increased in a superadditive manner. The enhancing activity of serum from neutropenic patients differed from that of normal serum. Especially, the addition of serum from the patient with Kostmann type CN to normal marrow cultures did not show this enhancement effect. The sera of patients with benign neutropenia had less enhancement effect than did normal control serum. These findings might be interpreted as showing an imbalance between CSF enhancer and inhibitors in the patients' serum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877459     DOI: 10.1002/ajh.2830200304

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments GCSF proliferation activity but not through the MAP kinase cascade.

Authors:  Toshihiro Yokoyama; Seiichi Okamura; Yoshinobu Asano; Kenjirou Kamezaki; Akihiko Numata; Haruko Kakumitsu; Koutarou Shide; Hitoshi Nakashima; Kanaji Taisuke; Yuichi Sekine; Yumi Mizuno; Jun Okamura; Tadashi Matsuda; Mine Harada; Niho Yoshiyuki; Kazuya Shimoda
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

2.  Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.

Authors:  A C Ward; Y M van Aesch; J Gits; A M Schelen; J P de Koning; D van Leeuwen; M H Freedman; I P Touw
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

3.  Reduction of CFU-GM and circulating hematopoietic progenitors in a subgroup of children with chronic neutropenia associated with severe infections and delayed recovery.

Authors:  Fabio Timeus; Nicoletta Crescenzio; Luiselda Foglia; Alessandra Doria; Maria Giuseppina Stillitano; Emanuela Garelli; Raffaela Mazzone; Laura Vivalda; Stefano Vallero; Ugo Ramenghi; Paola Saracco
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.